Literature DB >> 29148378

Outbreak of Yellow Fever among Nonhuman Primates, Espirito Santo, Brazil, 2017.

Natália Coelho Couto de Azevedo Fernandes, Mariana Sequetin Cunha, Juliana Mariotti Guerra, Rodrigo Albergaria Réssio, Cinthya Dos Santos Cirqueira, Silvia D'Andretta Iglezias, Júlia de Carvalho, Emerson L L Araujo, José Luiz Catão-Dias, Josué Díaz-Delgado.   

Abstract

In January 2017, a yellow fever outbreak occurred in Espirito Santo, Brazil, where human immunization coverage is low. Histologic, immunohistologic, and PCR examinations were performed for 22 deceased nonhuman New World primates; typical yellow fever features were found in 21. Diagnosis in nonhuman primates prompted early public health response.

Entities:  

Keywords:  Brazil; arboviruses; epizootics; nonhuman primates; outbreak; pathology; primates; virology; viruses; yellow fever; zoonoses

Mesh:

Substances:

Year:  2017        PMID: 29148378      PMCID: PMC5708241          DOI: 10.3201/eid2312.170685

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Yellow fever is a reemerging, zoonotic, noncontagious viral hemorrhagic disease endemic to Africa and South America; outbreaks occasionally occur among human and nonhuman primates (). It is caused by the yellow fever virus (family Flaviviridae, genus Flavivirus), which is carried by the vector mosquitoes Haemagogus and Sabethes (sylvatic cycle) and Aedes aegypti (urban cycle) (). Presumptive first reports of infection with yellow fever virus occurred ≈500 years ago (San Domingo, 1498; western Africa, 1585), and the first epidemics were recorded in the 17th century (Barbados, Cuba, and Mexico) (–). By the 18th century, epidemics were already deemed a threat for public health in the Old and New Worlds; transoceanic migrations played a major role in virus spread (,). After entering Brazil by the coast in the 17th century, the virus was gradually displaced to northwestern and midwestern areas. Since the 19th century, yellow fever outbreaks occurred in many cities in Brazil, until 1942, when the urban cycle was eradicated. By the late 1900s through the first decade of the 21st century, beginning in 1997, intense virus circulation extended from the Amazon region to the contiguous states of Goiás and Mato Grosso do Sul (central Brazil). During 2008–2009, a new outbreak was registered and the virus reached southern and southeast regions of the country (). In 2017, an epizootic occurred in Espirito Santo state, Brazil, where yellow fever virus has not circulated in the past 50 years and human vaccination coverage is low. We performed diagnostics on a small cohort of New World nonhuman primates in this state.

The Study

In January 2017, an outbreak involving deaths of humans and New World nonhuman primates (hereafter nonhuman primates [NHPs]) spread from Minas Gerais state to Espirito Santo state. Espirito Santo is located in a forest along the Atlantic coast of southeastern Brazil and borders Minas Gerais, Rio de Janeiro, and Bahia states. The virus advanced through Atlantic forest fragments (), areas previously considered not at risk for yellow fever virus transmission. We performed histopathologic analyses, immunohistochemical analyses (IHC), and PCRs on 22 NHPs that died early in the Espirito Santo outbreak (Figure 1).
Figure 1

Locations (red shading) of nonhuman primates that died of yellow fever, Espirito Santo, Brazil, January 2017. Inset shows location of Espirito Santo (light gray shading) and 4 other states within Brazil. GO, Goias; MG, Minas Gerais; MT, Mato Grosso do Sul; SP, São Paulo.

Locations (red shading) of nonhuman primates that died of yellow fever, Espirito Santo, Brazil, January 2017. Inset shows location of Espirito Santo (light gray shading) and 4 other states within Brazil. GO, Goias; MG, Minas Gerais; MT, Mato Grosso do Sul; SP, São Paulo. Veterinarians trained by health authorities performed standardized necropsies under the yellow fever national surveillance program (). Of 22 NHPs found dead, 2 were howler monkeys (Alouatta spp.) and 20 were NHPs not further identified. Liver, spleen, kidney, heart, and lung samples were collected and fixed in 10% neutral buffered formalin and processed for routine histopathology and in liquid nitrogen for RNA real-time reverse transcription quantitative PCR. Histologic examination indicated the following for all animals: zonal bridging (largely midzonal and centrilobular) or massive liver necrosis with Councilman bodies, varying degrees of macrovacuolar and microvacuolar steatosis, and pleocellular (mainly lymphohistiocytic) inflammatory infiltrates, accompanied by hemorrhage and hemosiderosis (Figure 2, panels A, B; Technical Appendix Table 1). Additional liver lesions were microabscesses (6), endothelial necrosis (5), oval cell hyperplasia (2), massive macrovacuolar steatosis with rare midzonal to random single-cell necrosis (1) (Figure 2, panel C), and fibrin microthrombi in sinusoids (1). Other consistent findings were splenic lymphoid depletion and follicular necrosis/lymphocytolysis (19), acute renal tubular necrosis with protein casts and hemoglobin casts (6), and multisystemic hemorrhage, more prominent in lungs (6).
Figure 2

Histopathologic and immunohistochemical findings in the livers of neotropical nonhuman primates that died of yellow fever, Espirito Santo, Brazil, January 2017. Asterisks (*) indicate centrilobular veins. A) Midzonal and centrilobular bridging hepatocellular lytic necrosis. Original magnification ×40; hematoxylin and eosin (H&E) staining. Inset shows lytic hepatocellular necrosis with multiple Councilman-Rocha Lima (apoptotic) bodies (arrows). Original magnification ×400; H&E staining. B) Massive (diffuse) hepatocellular lytic necrosis with severe centrilobular and midzonal hemorrhage. Original magnification ×40; H&E staining. Inset shows prominent hepatocellular necrosis and dropout, and erythrocytes replace the hepatic cords (there is some artifactual formalin pigment [acid hematin] in necrotic hepatocytes). Original magnification ×400; H&E staining. C) Massive macrovacuolar steatosis. Inset shows massive macrovacuolar steatosis mingled with single-cell hepatocellular necrosis (arrow). Original magnification ×400; H&E staining. D) Positive immunolabeling confined to remaining periportal hepatocytes and terminal plate. Original magnification ×40; immunohistochemical staining for yellow fever virus. Inset shows positive granular, cytoplasmic immunolabeling for yellow fever virus antigen in periportal hepatocytes and terminal plate. Original magnification ×400; immunohistochemical staining for yellow fever virus.

Histopathologic and immunohistochemical findings in the livers of neotropical nonhuman primates that died of yellow fever, Espirito Santo, Brazil, January 2017. Asterisks (*) indicate centrilobular veins. A) Midzonal and centrilobular bridging hepatocellular lytic necrosis. Original magnification ×40; hematoxylin and eosin (H&E) staining. Inset shows lytic hepatocellular necrosis with multiple Councilman-Rocha Lima (apoptotic) bodies (arrows). Original magnification ×400; H&E staining. B) Massive (diffuse) hepatocellular lytic necrosis with severe centrilobular and midzonal hemorrhage. Original magnification ×40; H&E staining. Inset shows prominent hepatocellular necrosis and dropout, and erythrocytes replace the hepatic cords (there is some artifactual formalin pigment [acid hematin] in necrotic hepatocytes). Original magnification ×400; H&E staining. C) Massive macrovacuolar steatosis. Inset shows massive macrovacuolar steatosis mingled with single-cell hepatocellular necrosis (arrow). Original magnification ×400; H&E staining. D) Positive immunolabeling confined to remaining periportal hepatocytes and terminal plate. Original magnification ×40; immunohistochemical staining for yellow fever virus. Inset shows positive granular, cytoplasmic immunolabeling for yellow fever virus antigen in periportal hepatocytes and terminal plate. Original magnification ×400; immunohistochemical staining for yellow fever virus. For IHC, we tested liver tissue sections with an in-house primary polyclonal anti–yellow fever virus antibody (1:40,000, derived from hyperimmune mouse serum); signal amplification was achieved with a HiDef Detection HRP Polymer System (Cell Marque/Sigma-Aldrich, Rocklin, CA, USA) and visualization with diaminobenzidine (D-5637; Sigma-Aldrich, St. Louis, MO, USA). We included human and nonhuman primate positive and negative control tissues with omitted first-layer antibody. Tissue from all animals showed positive granular cytoplasmic hepatocyte immunolabeling, with varying percentages of involvement and immunolabeling intensity (Technical Appendix Table 2). Immunopositivity was more intense in degenerating and remaining hepatocytes, most often encompassing periportal cord segments and terminal plates (Figure 2, panel D). Necrotic hepatocytes consistently lacked immunoreactivity. For PCRs, we extracted viral RNA from whole blood (n = 6); serum (n = 1); and liver, kidney, and spleen (n = 4) tissue samples by using a QIAamp RNA Blood Mini Kit (QIAGEN, Valencia, CA, USA), following the manufacturer’s instructions. We amplified virus fragment by using the protocol designed by Drosten et al. (), which targets the 5′ noncoding region (112-bp long) of the genome. All samples were positive; cycle thresholds were 11–26 (cutoff value 38; Technical Appendix Table 2). Brazil has an established yellow fever national surveillance program (e.g., postmortem NHP studies, vector analyses) focused on early detection of virus circulation, which enables prompt implementation of vaccination and vector control (). Yellow fever diagnosis under this program is achieved by histopathologic, IHC, and PCR results from liver samples of NHPs, performed by reference laboratories (e.g., Adolfo Lutz Institute, São Paulo, Brazil). A multidisciplinary work team and combination of laboratory techniques are essential for a quick, high-quality response that initiates field actions (e.g., vaccination, vector control). We observed classic histopathologic commonalities with yellow fever–associated disease in humans (midzonal lytic necrosis, apoptotic bodies, steatosis, and scarce paucicellular inflammation) (,). The severity and extent of these lesions probably accounted for severe hepatic failure and death of the animals. The knowledge of naturally occurring yellow fever–associated disease in NHPs gained since the early 1900s is fragmentary () and mainly limited to Alouatta spp. and Callithrix spp. NHPs (,). Alouatta spp. monkeys are very susceptible to yellow fever; fatal disease has supported a sentinel role for yellow fever virus circulation since the 1930s (). Hepatic lesions of several NHP species, experimentally or naturally infected, are similar to those in humans (). In this study, 1 animal had atypical liver histopathologic features, characterized by massive steatosis with rare midzonal to random single-cell necrosis/apoptosis. Additional liver findings were multifocal microabscesses, probably the result of acute bacterial ascending (intestinal) infection or concomitant septicemia; endothelial necrosis; and attempted hepatic regeneration as suggested by oval cell hyperplasia. The pathologic signature of yellow fever–associated disease in NHPs (≈150 species) is not fully resolved. Ongoing comparisons between yellow fever–associated disease in humans and NHPs may help elucidate convergent and divergent pathogenetic mechanisms and characterize typical and atypical features, thus delineating the pathologic signature in NHPs. Before the advent of PCR, the method of choice for diagnosing yellow fever was IHC, which remains a highly reliable diagnostic tool (), even in the presence of some autolysis (). In our study and the ongoing outbreak, histopathologic analyses and IHC were vital for successful diagnosis, enabling detection of atypical presentation, paralleling the sensitivity and specificity of PCRs. In a public health context, IHC will greatly aid in yellow fever diagnosis when molecular analysis is not an option, as occurred for 11 of 22 cases in this study. Although RNA extraction from paraffin-embedded tissues is possible, it is not extensively applied and the degradation of RNA may lead to false-negative results.

Conclusions

During January–July 2017, yellow fever was diagnosed for 150 of 1,000 tested NHPs (15% occurrence) from southern states of Brazil. NHPs were effective yellow fever sentinels and enabled rapid government response (,). Although the Espirito Santo outbreak had damaging socioeconomic and environmental consequences, adequate case conduction and diagnosis may have prevented further human deaths and diminished disease expansion. In contrast, the effects of yellow fever virus spreading among NHPs in the Atlantic forest are expected to be devastating.

Technical Appendix

Histology, immunohistology, and molecular analysis results for 22 nonhuman primates that died of yellow fever, Espirito Santo, Brazil, 2017.
  10 in total

Review 1.  Epidemiology and ecology of yellow fever virus.

Authors:  Alan D Barrett; Thomas P Monath
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Frequency of histopathological changes in Howler monkeys ( Alouatta sp.) naturally infected with yellow fever virus in Brazil.

Authors:  Silvana Gomes Leal; Alessandro Pecego Martins Romano; Rafael Veríssimo Monteiro; Cristiano Barros de Melo; Pedro Fernando da Costa Vasconcelos; Márcio Botelho de Castro
Journal:  Rev Soc Bras Med Trop       Date:  2016-02       Impact factor: 1.581

Review 3.  Yellow fever.

Authors:  Thomas P Monath; Pedro F C Vasconcelos
Journal:  J Clin Virol       Date:  2014-10-24       Impact factor: 3.168

4.  Histopathology of the human liver in yellow fever with special emphasis on the diagnostic role of the Councilman body.

Authors:  W T Vieira; L C Gayotto; C P de Lima; T de Brito
Journal:  Histopathology       Date:  1983-03       Impact factor: 5.087

Review 5.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

6.  Detection of a new yellow fever virus lineage within the South American genotype I in Brazil.

Authors:  Renato P de Souza; Peter G Foster; Maria Anice M Sallum; Terezinha L M Coimbra; Adriana Y Maeda; Vivian R Silveira; Eduardo S Moreno; Fernanda G da Silva; Iray M Rocco; Ivani B Ferreira; Akemi Suzuki; Fabíola M Oshiro; Selma M C N Petrella; Luiz E Pereira; Giselda Katz; Cilea H Tengan; Melissa M Siciliano; Cecília L S Dos Santos
Journal:  J Med Virol       Date:  2010-01       Impact factor: 2.327

7.  Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis.

Authors:  W C Hall; T P Crowell; D M Watts; V L Barros; H Kruger; F Pinheiro; C J Peters
Journal:  Am J Trop Med Hyg       Date:  1991-10       Impact factor: 2.345

8.  [Experimental transmission of the yellow fever virus by the tick Amblyomma variegatum (F.) (author's transl)].

Authors:  J P Cornet; M Huard; J L Camicas; J P Hervé; M Germain
Journal:  Bull Soc Pathol Exot Filiales       Date:  1982 Mar-Apr

9.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination.

Authors:  Marco A B Almeida; Jader da C Cardoso; Edmilson Dos Santos; Daltro F da Fonseca; Laura L Cruz; Fernando J C Faraco; Marilina A Bercini; Kátia C Vettorello; Mariana A Porto; Renate Mohrdieck; Tani M S Ranieri; Maria T Schermann; Alethéa F Sperb; Francisco Z Paz; Zenaida M A Nunes; Alessandro P M Romano; Zouraide G Costa; Silvana L Gomes; Brendan Flannery
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13
  10 in total
  18 in total

1.  Detection and Molecular Characterization of Yellow Fever Virus, 2017, Brazil.

Authors:  P O Figueiredo; A T S Silva; J S Oliveira; P E Marinho; F T Rocha; G P Domingos; P C P Poblete; L B S Oliveira; D C Duarte; C A Bonjardim; J S Abrahão; E G Kroon; B P Drumond; D B Oliveira; G S Trindade
Journal:  Ecohealth       Date:  2018-08-16       Impact factor: 3.184

2.  Predicting Yellow Fever Through Species Distribution Modeling of Virus, Vector, and Monkeys.

Authors:  Marco A B de Almeida; Edmilson Dos Santos; Jáder da C Cardoso; Lucas G da Silva; Rafael M Rabelo; Júlio César Bicca-Marques
Journal:  Ecohealth       Date:  2018-12-17       Impact factor: 3.184

Review 3.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-07-10

Review 4.  Yellow fever in Africa and the Americas: a historical and epidemiological perspective.

Authors:  Jean-Philippe Chippaux; Alain Chippaux
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-08-25

5.  Epizootics due to Yellow Fever Virus in São Paulo State, Brazil: viral dissemination to new areas (2016-2017).

Authors:  Mariana Sequetin Cunha; Antonio Charlys da Costa; Natália Coelho Couto de Azevedo Fernandes; Juliana Mariotti Guerra; Fabiana Cristina Pereira Dos Santos; Juliana Silva Nogueira; Leandro Guariglia D'Agostino; Shirley Vasconcelos Komninakis; Steven S Witkin; Rodrigo Albergaria Ressio; Adriana Yurika Maeda; Fernanda Gisele Silva Vasami; Ursula Mitsue Abreu Kaigawa; Laís Sampaio de Azevedo; Paloma Alana de Souza Facioli; Fernando Luiz Lima Macedo; Ester Cerdeira Sabino; Élcio Leal; Renato Pereira de Souza
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

6.  Yellow fever: profile of cases and factors associated with death in a hospital in the State of Rio de Janeiro, 2017-2018.

Authors:  Claudia Caminha Escosteguy; Alessandra Gonçalves Lisbôa Pereira; Marcio Renan Vinícius Espínola Marques; Tatiana Rodrigues de Araujo Lima; Rafael Mello Galliez; Roberto de Andrade Medronho
Journal:  Rev Saude Publica       Date:  2019-10-21       Impact factor: 2.106

Review 7.  Mosquito-Borne Diseases Emergence/Resurgence and How to Effectively Control It Biologically.

Authors:  Handi Dahmana; Oleg Mediannikov
Journal:  Pathogens       Date:  2020-04-23

8.  Evidence of natural Zika virus infection in neotropical non-human primates in Brazil.

Authors:  Ana Carolina B Terzian; Nathalia Zini; Lívia Sacchetto; Rebeca Froes Rocha; Maisa Carla Pereira Parra; Juliana Lemos Del Sarto; Ana Carolina Fialho Dias; Felipe Coutinho; Jéssica Rayra; Rafael Alves da Silva; Vivian Vasconcelos Costa; Natália Coelho Couto De Azevedo Fernandes; Rodrigo Réssio; Josué Díaz-Delgado; Juliana Guerra; Mariana S Cunha; José Luiz Catão-Dias; Cintia Bittar; Andréia Francesli Negri Reis; Izalco Nuremberg Penha Dos Santos; Andréia Cristina Marascalchi Ferreira; Lilian Elisa Arão Antônio Cruz; Paula Rahal; Leila Ullmann; Camila Malossi; João Pessoa de Araújo; Steven Widen; Izabela Maurício de Rezende; Érica Mello; Carolina Colombelli Pacca; Erna Geessien Kroon; Giliane Trindade; Betânia Drumond; Francisco Chiaravalloti-Neto; Nikos Vasilakis; Mauro M Teixeira; Maurício Lacerda Nogueira
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

9.  Modeling the elevated risk of yellow fever among travelers visiting Brazil, 2018.

Authors:  Yohei Sakamoto; Takayuki Yamaguchi; Nao Yamamoto; Hiroshi Nishiura
Journal:  Theor Biol Med Model       Date:  2018-07-02       Impact factor: 2.432

Review 10.  Yellow fever in the diagnostics laboratory.

Authors:  Cristina Domingo; Rémi N Charrel; Jonas Schmidt-Chanasit; Hervé Zeller; Chantal Reusken
Journal:  Emerg Microbes Infect       Date:  2018-07-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.